| Anaerostipes hadrus| Anaerostipes hadrus (Moore et al. 1976) Allen-Vercoe et al. 2013| Anaerostipes sp. 5/1/63FAA| ATCC 29173| butyrate-producing bacterium SS2/1| butyrate-producing bacterium SSC/2| Clostridiales bacterium SSC/2| DSM 3319| Eubacterium hadrum| Eubacterium hadrum Moore et al. 1976| JCM 9980| VP 82-52| VPI B2-52
Gut Microbiota: Bifidobacterium species, including Bifidobacterium indicum, are commonly found in the human gastrointestinal tract, where they contribute to the complex microbial community.
Probiotic Potential: Bifidobacteria are often considered probiotics, which are live microorganisms that, when administered in adequate amounts, confer a health benefit to the host. Probiotics, including certain Bifidobacterium strains, have been associated with various potential health benefits.
Fermentation and Short-Chain Fatty Acid Production: Bifidobacterium species are known for their ability to ferment dietary fibers, producing short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate. SCFAs are thought to have several beneficial effects on gut health, including supporting the integrity of the intestinal lining.
Immunomodulation: Some studies suggest that Bifidobacterium species may have immunomodulatory effects, influencing the activity of the immune system and promoting a balanced immune response.
Limited Specific Information: As of my last update, specific information on the health impacts of Bifidobacterium indicum is not extensively documented in the available scientific literature. The exploration of specific Bifidobacterium species and their potential health effects is an active area of research.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 4.72 | 0 | 0 | 110 | 75322 | 0 | 48801 | 15890.4 | 10511 | 16790.9 | 0 | 34089 | 0 %ile | 100 %ile |
thorne | 100 | 753 | 33119 | 0 | 30708 | 11610.5 | 9175 | 9743.6 | 0 | 27759 | 0 %ile | 100 %ile | ||
thryve | 97.38 | 97 | 19722 | 563 | 17103 | 0 | 53470 | 11515.8 | 5863 | 21405.2 | 0 | 20293 | 8 %ile | 90.6 %ile |
ubiome | 42.59 | 0 | 98 | 55 | 39136 | 0 | 25904 | 4394.2 | 238 | 10974.3 | 0 | 4974 | 8 %ile | 98.2 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 1197 | 5777 | 0.1197 | 0.5777 |
XenoGene | 20000 | 990000 | 2 | 99 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
bugspeak | 100 % | 0.046 % | % | 1.0 | 1 |
CerbaLab | 100 % | 0.837 % | 0.361 % | 3.0 | 3 |
CosmosId | 93.75 % | 2.694 % | 2.228 % | 30.0 | 32 |
custom | 29.508 % | 2.911 % | 1.882 % | 18.0 | 61 |
es-xenogene | 75.862 % | 2.046 % | 1.765 % | 22.0 | 29 |
Microba | 75 % | 1.107 % | 1.238 % | 21.0 | 28 |
SequentiaBiotech | 91.667 % | 1.036 % | 1.098 % | 33.0 | 36 |
Thorne | 89.423 % | 0.773 % | 0.845 % | 93.0 | 104 |
Thryve | 97.198 % | 1.172 % | 2.378 % | 1353.0 | 1392 |
Tiny | 100 % | 1.839 % | 0.587 % | 2.0 | 2 |
uBiome | 42.424 % | 0.439 % | 1.097 % | 336.0 | 792 |
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.